Experience in Borderline Ovarian Tumors
Not yet recruiting
- Conditions
- Borderline Ovarian Tumor
- Registration Number
- NCT05791838
- Lead Sponsor
- University of Palermo
- Brief Summary
Borderline ovarian tumors (BOTs) comprise 15-20% of primary ovarian neoplasms and represent an independent disease entity among epithelial ovarian cancers. The present study aimed to report the 8-year experience of a single center on the management and outcomes of consecutive BOTs patients. From January 2010 to December 2017, all patients with BOTs undergoing surgical treatment were included. Demographic, clinical, and pathological data were reviewed retrospectively.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- Female
- Target Recruitment
- 86
Inclusion Criteria
- Age > 18 years,
- Patients affected by borderline ovarian tumors (BOT) of any histological type and any FIGO stage,
- Women undergoing surgical treatment with both laparoscopic and laparotomic approaches.
Exclusion Criteria
- Women affected by ovarian cancers
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Oncological outcome through study completion, an average of 1 year Patients who underwent surgery for BOT
- Secondary Outcome Measures
Name Time Method